
Levocetirizine (5mg) + Montelukast (10mg)
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Evonast-LC Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, formulated to provide effective relief from allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation antihistamine, works by selectively blocking peripheral H1 receptors, thereby reducing symptoms like sneezing, runny nose, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, inhibits the action of leukotrienes, which are inflammatory chemicals responsible for bronchoconstriction, mucus production, and airway inflammation, making it particularly useful in managing asthma and allergic rhinitis. The combination of these two agents offers a synergistic effect, addressing both immediate histamine-mediated allergic reactions and the prolonged inflammatory response. Evonast-LC is typically prescribed for patients who require comprehensive management of allergic symptoms, improving overall respiratory function and quality of life. It is generally well-tolerated, with minimal side effects such as headache, fatigue, or gastrointestinal discomfort. However, it should be used under medical supervision, especially in patients with liver or kidney impairment. This tablet is taken orally, usually once daily in the evening, to maximize efficacy and patient compliance.
How to use Evonast-LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Evonast-LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Evonast-LC Tablet. Please consult your doctor.
High Risk
Evonast-LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Evonast-LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Evonast-LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Evonast-LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Evonast-LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Evonast-LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Evonast-LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Evonast-LC Tablet may be needed. Please consult your doctor. Use of Evonast-LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Evonast-LC Tablet

Levocetirizine (5mg) + Montelukast (10mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Levocetirizine selectively antagonizes H1 histamine receptors, inhibiting the effects of histamine in allergic responses.
Montelukast selectively antagonizes leukotriene receptors, inhibiting their effects on bronchoconstriction and inflammation.
Medical applications
Evonast-LC Tablet is a combination medication containing Levocetirizine 5mg and Montelukast 10mg, formulated to provide effective relief from allergic conditions such as allergic rhinitis and chronic urticaria. Levocetirizine, a third-generation antihistamine, works by selectively blocking peripheral H1 receptors, thereby reducing symptoms like sneezing, runny nose, itching, and watery eyes. Montelukast, a leukotriene receptor antagonist, inhibits the action of leukotrienes, which are inflammatory chemicals responsible for bronchoconstriction, mucus production, and airway inflammation, making it particularly useful in managing asthma and allergic rhinitis. The combination of these two agents offers a synergistic effect, addressing both immediate histamine-mediated allergic reactions and the prolonged inflammatory response. Evonast-LC is typically prescribed for patients who require comprehensive management of allergic symptoms, improving overall respiratory function and quality of life. It is generally well-tolerated, with minimal side effects such as headache, fatigue, or gastrointestinal discomfort. However, it should be used under medical supervision, especially in patients with liver or kidney impairment. This tablet is taken orally, usually once daily in the evening, to maximize efficacy and patient compliance.
How to use Evonast-LC Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Evonast-LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Caution is advised when consuming alcohol with Evonast-LC Tablet. Please consult your doctor.
High Risk
Evonast-LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Evonast-LC Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Exercise Caution
Evonast-LC Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Evonast-LC Tablet may be needed. Please consult your doctor. Limited information is available on the use of Evonast-LC Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.
Regular Checkup
Evonast-LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Evonast-LC Tablet should be used with caution in patients with kidney disease. Dose adjustment of Evonast-LC Tablet may be needed. Please consult your doctor. Use of Evonast-LC Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Evonast-LC Tablet















